Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-19 06:29 am Purchase | 2024-12-18 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 48,792,335 70.600% | 169,110 (+0.35%) | Filing History |
| 2024-09-13 5:54 pm Purchase | 2024-09-11 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 555,736,060 75.200% | 379,871,779 (+216.00%) | Filing History |
| 2024-07-08 3:30 pm Purchase | 2024-07-03 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 48,623,225 72.900% | 10,647,906 (+28.04%) | Filing History |
| 2023-12-14 7:21 pm Purchase | 2023-12-12 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 37,975,319 68.800% | 521,059 (+1.39%) | Filing History |
| 2023-12-04 5:18 pm Purchase | 2023-11-28 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 37,454,260 67.800% | 549,380 (+1.49%) | Filing History |
| 2023-05-10 5:43 pm Purchase | 2023-05-09 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 36,904,880 68.700% | 10,150,071 (+37.94%) | Filing History |
| 2023-02-16 4:01 pm Unchanged | 2023-02-07 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 175,864,281 78.100% | 0 (Unchanged) | Filing History |
| 2022-12-09 5:24 pm Purchase | 2022-12-06 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 175,864,281 81.800% | 9,346,434 (+5.61%) | Filing History |
| 2022-08-18 4:43 pm Purchase | 2022-08-16 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 166,517,847 81.150% | 94,870,338 (+132.41%) | Filing History |
| 2022-06-10 6:53 pm Purchase | 2022-06-09 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 26,754,809 62.100% | 11,558,314 (+76.06%) | Filing History |
| 2021-07-02 5:01 pm Purchase | 2021-06-30 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 15,196,495 51.200% | 3,053,780 (+25.15%) | Filing History |
| 2021-05-14 4:27 pm Purchase | 2021-05-12 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 71,647,509 70.780% | 11,365,921 (+18.85%) | Filing History |
| 2021-05-11 4:34 pm Purchase | 2021-04-14 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 12,142,715 45.600% | 42,431 (+0.35%) | Filing History |
| 2021-04-22 5:11 pm Unchanged | 2021-04-20 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.370% | 0 (Unchanged) | Filing History |
| 2021-03-26 5:07 pm Unchanged | 2021-03-24 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.370% | 0 (Unchanged) | Filing History |
| 2020-11-10 4:11 pm Purchase | 2020-11-06 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 60,281,588 69.940% | 4,341,317 (+7.76%) | Filing History |
| 2020-10-06 7:28 pm Purchase | 2020-10-02 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 55,940,271 69.110% | 9,730,539 (+21.06%) | Filing History |
| 2020-09-28 4:37 pm Purchase | 2020-09-18 | 13D | Summit Therapeutics Inc. SMMT | DUGGAN ROBERT W | 46,209,732 64.890% | 46,209,732 (New Position) | Filing History |
| 2020-06-17 4:36 pm Purchase | 2020-06-15 | 13D | Pulse Biosciences, Inc. PLSE | DUGGAN ROBERT W | 12,100,284 47.200% | 3,019,553 (+33.25%) | Filing History |